Invega (paliperidone) is being promoted as a new atypical antipsychotic for schizophrenia

Invega (paliperidone) is being promoted as a new atypical antipsychotic for schizophrenia.

But the ingredient in Invega is not really that new...it's the active metabolite of risperidone (Risperdal).

Expect Invega to work as well as risperidone, and have similar side effects such as restlessness or extrapyramidal symptoms.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote